abrdn World Healthcare Fund
About this Fund
The abrdn World Healthcare Fund is a prominent player in the asset management industry, specializing in mutual fund investments that cater to a diverse range of investors seeking to tap into the growth potential of the global healthcare sector. As a leading investment company, abrdn offers a comprehensive portfolio of mutual funds, including equity, debt, and hybrid funds, designed to meet the unique needs and risk profiles of its clients. With a strong focus on wealth management, the company's investment strategies are geared towards delivering long-term value to its investors, while also providing a stable and secure foundation for their financial futures. By leveraging its expertise in active management, abrdn's experienced team of investment professionals works closely with clients to create customized portfolios that align with their individual goals and objectives, whether through systematic investment plans (SIPs) or other investment vehicles. The company's equity funds, for instance, offer investors the opportunity to capitalize on the growth potential of the global healthcare sector, which is driven by an aging population, advancements in medical technology, and increasing demand for healthcare services. On the other hand, its debt funds provide a more conservative investment option, focusing on generating regular income through investments in high-quality bonds and other fixed-income securities. For investors seeking a balanced approach, abrdn's hybrid funds offer a mix of equity and debt investments, carefully managed to optimize returns while minimizing risk. With a proven track record of delivering strong investment performance, abrdn has established itself as a trusted partner for investors seeking to navigate the complexities of the mutual fund landscape. By combining its investment expertise with a deep understanding of the markets and a commitment to exceptional client service, the company has built a loyal following among investors who value its ability to help them achieve their financial goals. As a result, investors trust abrdn to manage their investments, whether through its World Healthcare Fund or other mutual fund offerings, confident in the company's ability to provide a stable and secure foundation for their financial futures, while also delivering the potential for long-term growth and wealth creation. With its strong investment capabilities, client-centric approach, and dedication to excellence, abrdn is well-positioned to continue meeting the evolving needs of its investors, while also staying at the forefront of the asset management industry. By offering a range of investment solutions, including mutual funds, SIPs, and other wealth management products, the company is able to cater to a broad range of investor needs, from those seeking aggressive growth to those prioritizing capital preservation. Through its active management approach, abrdn's investment team is able to identify opportunities for growth and income, while also mitigating risk and protecting investor capital. As a trusted and experienced investment partner, abrdn is committed to helping its clients achieve their financial goals, whether through its World Healthcare Fund or other mutual fund offerings, and to delivering exceptional investment performance and client service over the long term.
Holdings
From latest SEC N-PORT filing · US-listed stocks only
| # | Security Name | CUSIP | Asset Type | Weight % | Value ($M) | Quantity |
|---|---|---|---|---|---|---|
| 1 | ABT Abbott Laboratories Since 2026-05-10 | 002824100 | Equity (Common) |
3.63%
|
$19.00 | 151,692 |
| 2 | ABT ABBOTT LABORATORIES Since 2026-05-10 | 002824BG4 | Debt |
1.09%
|
$5.69 | 5,652,000 |
| 3 | ABBV AbbVie Inc Since 2026-05-10 | 00287Y109 | Equity (Common) |
3.85%
|
$20.18 | 88,295 |
| 4 | ABBV ABBVIE INC Since 2026-05-10 | 00287YAR0 | Debt |
0.60%
|
$3.14 | 3,200,000 |
| 5 | ABBV ABBVIE INC Since 2026-05-10 | 00287YAW9 | Debt |
0.28%
|
$1.48 | 1,705,000 |
| 6 | AZN AstraZeneca PLC Since 2026-05-10 | 046353108 | Equity (Common) |
6.43%
|
$33.67 | 366,265 |
| 7 | CDNA CareDx Inc Since 2026-05-10 | 14167L103 | Equity (Common) |
0.48%
|
$2.52 | 133,874 |
| 8 | CRL Charles River Laboratories International Inc Since 2026-05-10 | 159864107 | Equity (Common) |
0.68%
|
$3.58 | 17,923 |
| 9 | DXCM Dexcom Inc Since 2026-05-10 | 252131107 | Equity (Common) |
0.76%
|
$4.00 | 60,255 |
| 10 | IRON Disc Medicine Inc Since 2026-05-10 | 254604101 | Equity (Common) |
0.59%
|
$3.06 | 38,603 |
| 11 | DHC Diversified Healthcare Trust Since 2026-05-10 | 25525P107 | Equity (Common) |
0.06%
|
$0.31 | 63,841 |
| 12 | DOC Healthpeak Properties Inc Since 2026-05-10 | 42250P103 | Equity (Common) |
1.01%
|
$5.28 | 328,042 |
| 13 | HUM Humana Inc Since 2026-05-10 | 444859102 | Equity (Common) |
1.34%
|
$7.01 | 27,360 |
| 14 | IMUX Immunic Inc Since 2026-05-10 | 4525EP101 | Equity (Common) |
0.05%
|
$0.25 | 476,254 |
| 15 | INSP Inspire Medical Systems Inc Since 2026-05-10 | 457730109 | Equity (Common) |
1.39%
|
$7.28 | 78,972 |
| 16 | ISRG Intuitive Surgical Inc Since 2026-05-10 | 46120E602 | Equity (Common) |
2.85%
|
$14.96 | 26,406 |
| 17 | IQV IQVIA Holdings Inc Since 2026-05-10 | 46266C105 | Equity (Common) |
0.85%
|
$4.43 | 19,654 |
| 18 | LTC LTC Properties Inc Since 2026-05-10 | 502175102 | Equity (Common) |
0.42%
|
$2.18 | 63,514 |
| 19 | MDT MEDTRONIC INC Since 2026-05-10 | 585055BT2 | Debt |
0.31%
|
$1.64 | 1,675,000 |
| 20 | MRK Merck & Co Inc Since 2026-05-10 | 58933Y105 | Equity (Common) |
3.56%
|
$18.67 | 177,381 |
| 21 | MOH Molina Healthcare Inc Since 2026-05-10 | 60855R100 | Equity (Common) |
0.83%
|
$4.35 | 25,063 |
| 22 | NHI National Health Investors Inc Since 2026-05-10 | 63633D104 | Equity (Common) |
0.06%
|
$0.34 | 4,442 |
| 23 | NVO Novo Nordisk A/S Since 2026-05-10 | 670100205 | Equity (Common) |
5.97%
|
$31.28 | 614,866 |
| 24 | OHI Omega Healthcare Investors Inc Since 2026-05-10 | 681936100 | Equity (Common) |
0.60%
|
$3.15 | 71,075 |
| 25 | PFE PFIZER INC Since 2026-05-10 | 717081EC3 | Debt |
0.32%
|
$1.69 | 1,800,000 |
| 26 | PFE PFIZER INC Since 2026-05-10 | 717081ET6 | Debt |
1.00%
|
$5.24 | 5,300,000 |
| 27 | PRAX Praxis Precision Medicines Inc Since 2026-05-10 | 74006W207 | Equity (Common) |
1.62%
|
$8.51 | 28,865 |
| 28 | DTIL Precision BioSciences Inc Since 2026-05-10 | 74019P207 | Equity (Common) |
0.87%
|
$4.55 | 1,094,851 |
| 29 | SBRA Sabra Health Care REIT Inc Since 2026-05-10 | 78573L106 | Equity (Common) |
0.72%
|
$3.79 | 200,380 |
| 30 | TMO Thermo Fisher Scientific Inc Since 2026-05-10 | 883556102 | Equity (Common) |
2.03%
|
$10.62 | 18,333 |
| 31 | TMO THERMO FISHER SCIENTIFIC Since 2026-05-10 | 883556CY6 | Debt |
0.67%
|
$3.52 | 3,500,000 |
| 32 | VTR Ventas Inc Since 2026-05-10 | 92276F100 | Equity (Common) |
1.79%
|
$9.39 | 121,317 |
| 33 | WELL Welltower Inc Since 2026-05-10 | 95040Q104 | Equity (Common) |
1.53%
|
$8.01 | 43,157 |
| 34 | IMUX IMMUNIC INC. Since 2026-05-10 | — | Derivative | — | — | 3,108,929 |
| 35 | IMUX IMMUNIC INC. Since 2026-05-10 | — | Derivative |
0.32%
|
$1.66 | 3,108,929 |
| 36 | IMUX IMMUNIC INC. Since 2026-05-10 | — | Derivative |
0.12%
|
$0.61 | 3,108,929 |
| 37 | ZBH ZIMMER BIOMET HOLDINGS Since 2026-05-10 | 98956PAG7 | Debt |
0.89%
|
$4.65 | 5,000,000 |
| 38 | ZTS Zoetis Inc Since 2026-05-10 | 98978V103 | Equity (Common) |
1.79%
|
$9.38 | 74,572 |
| 39 | DTIL PRECISION BIOSCIENCES Since 2026-05-10 | — | Derivative |
0.18%
|
$0.92 | 396,233 |
| 40 | LIVN LivaNova PLC Since 2026-05-10 | — | Equity (Common) |
0.30%
|
$1.59 | 25,850 |
| 41 | MDT Medtronic PLC Since 2026-05-10 | — | Equity (Common) |
2.73%
|
$14.30 | 148,872 |
| 42 | PCSC Perceptive Capital Solutions Corp Since 2026-05-10 | — | Equity (Common) |
0.33%
|
$1.74 | 133,700 |
| 43 | OCS Oculis Holding AG Since 2026-05-10 | — | Equity (Common) |
1.31%
|
$6.87 | 343,874 |